Medrio
PrivateLast Round
Private Equity
May 24, 2017
Total Funding Raised
$32.03M
Company Overview
Medrio operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Private Equity round in May 2017.
Medrio is a healthcare technology company that provides a unified, cloud-based eClinical platform for clinical trials, including electronic data capture (EDC), ePRO, eConsent, and RTSM solutions.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Vertical SaaS, Biotechnology, Low-Code/No-Code
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medrio Comparables
Compare Medrio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Viedoc | 93% | |
| Castor | 89% | |
| OpenClinica | 85% |
For institutional investors. Book with your work email.
Medrio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | May 24, 2017 | ||||
| Seed | Oct 28, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Medrio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Questa Capital | Private Equity |
| Ulu Ventures | Seed |
| TSV Capital | Seed |
| SeedFolio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Partnerships announced with AG Mednet, Pharmaseal, and ThoughtSphere.
- Mar 26, 2025
Randomization and trial supply management solution updated.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 3, 2026
Medrio launches Medrio CTMS, built for small and scaling sponsors and CROs, through its Early Adopter Program in California on Nov 3rd '26.
- launchesNov 3, 2026
Medrio launches Medrio CTMS for small and scaling sponsors and CROs through its Early Adopter Program in California on Nov 3rd '26.
For institutional investors. Book with your work email.
Medrio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medrio's valuation, stock price, and market status.
Is Medrio a public or private company?
Medrio is a private company.
What is the current stock price of Medrio?
Medrio is a private company, so its shares have no public market price. Caplight tracks Medrio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medrio worth (valuation)?
Valuation information for Medrio is not publicly available.
Can I buy Medrio stock?
Medrio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medrio's last funding round?
Medrio's most recent funding round was Private Equity on May 24, 2017.
Who are the main investors in Medrio?
Key investors in Medrio include Questa Capital.
Will Medrio IPO soon?
No public IPO plans have been announced for Medrio.
How can I track Medrio secondary market activity?
Caplight tracks bids, offers, and trades in Medrio's shares on secondary markets.